- 1,704
Medicare Part D premiums to increase an average 14 percent
By Larry Lipman
Austin Statesman
Monday, August 13, 2007, 05:23 PM
The average premium for Medicare Part D, which covers prescription drugs, will increase about $3 a month, or nearly 14 percent, starting Jan. 1, Medicare officials announced Monday. The average premium will increase from about $22 to $25 a month.
Trying to put the best face on the increase, however, Medicare officials noted that the average premium is still far lower than what Medicare and congressional officials estimated when the drug law was passed in 2003.
Medicare officials attribute the lower-than-predicted premiums to the impact of competition among drug plans.
"Competition and smart choices have been two important factors in holding down the cost of the Medicare drug benefit," said Herb B. Kuhn, acting deputy administrator of the Centers for Medicare and Medicaid Services. "Medicare drug benefit bids continue to be well below projections because of slower than expected growth in prescription drug costs generally, in part because of increased generic usage, effective plan negotiation, and strong competition."
Medicare officials also note that most of the increase is due to technical factors in the way Medicare computes risk factors associated with the drug coverage.
Despite the increase, Medicare officials say 87 percent of beneficiaries enrolled in stand-alone drug plans will be able to find a plan with the same or even lower premiums than they now pay. The Part D program will have its third open enrollment period, in which beneficiaries can sign up for a different plan, from Nov. 15 to Dec. 31.
By Larry Lipman
Austin Statesman
Monday, August 13, 2007, 05:23 PM
The average premium for Medicare Part D, which covers prescription drugs, will increase about $3 a month, or nearly 14 percent, starting Jan. 1, Medicare officials announced Monday. The average premium will increase from about $22 to $25 a month.
Trying to put the best face on the increase, however, Medicare officials noted that the average premium is still far lower than what Medicare and congressional officials estimated when the drug law was passed in 2003.
Medicare officials attribute the lower-than-predicted premiums to the impact of competition among drug plans.
"Competition and smart choices have been two important factors in holding down the cost of the Medicare drug benefit," said Herb B. Kuhn, acting deputy administrator of the Centers for Medicare and Medicaid Services. "Medicare drug benefit bids continue to be well below projections because of slower than expected growth in prescription drug costs generally, in part because of increased generic usage, effective plan negotiation, and strong competition."
Medicare officials also note that most of the increase is due to technical factors in the way Medicare computes risk factors associated with the drug coverage.
Despite the increase, Medicare officials say 87 percent of beneficiaries enrolled in stand-alone drug plans will be able to find a plan with the same or even lower premiums than they now pay. The Part D program will have its third open enrollment period, in which beneficiaries can sign up for a different plan, from Nov. 15 to Dec. 31.